Instituto: INSTITUTO DE BIOLOGIA MOLECULAR Y CELULAR DEL CANCER DE SALAMANCA

DISSECTING THE PATHOBIOLOGICAL AND THERAPEUTIC ROLE OF A NEW ONCOGENIC DRIVER ON T CELL LYMPHOMAGENESIS